Biobytes
Latest round
- Seed
Last raised
- Nov 2024
Total raised
- $0.4M
Investors
- 4
About Biobytes
, Ltd. trading under the name Biobytes, operates as a company that uses AI to forecast and tackle sarcopenia, a condition associated with the loss of muscle mass as people age. Biobytes provides biotechnology solutions to address critical needs in healthcare, agriculture, and environmental protection. The company's primary product methods to analyze genetic data and biopesticides derived from natural organisms to protect crops. These solutions are employed by research institutes, farmers, and environmental scientists throughout North America, Europe, and Asia.
Who invested in Biobytes
4 investors across 2 rounds
See all investors in Biobytes
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Biobytes
Who invested in Biobytes?
Biobytes has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Biobytes raised?
Biobytes has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Biobytes last raise money?
Biobytes's most recent round on record is a Seed, in Nov 2024.
What does Biobytes do?
Biobytes is a healthcare company.
Where is Biobytes headquartered?
Biobytes is headquartered in Chuncheon-si, South Korea.
Which VCs invest in companies like Biobytes?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, MPCi, Zijin Venture Capital and Legend Capital back healthcare companies at Biobytes's stage. Their profiles are linked below.
VCs backing healthcare startups at Seed
Raising like Biobytes? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.